148 related articles for article (PubMed ID: 1711704)
1. Long-term effects of neonatal exposure to isobutylmethylxanthine. II. Attenuation of acute morphine withdrawal in mature rats.
Neal BS; Messing RB; Sparber SB
Psychopharmacology (Berl); 1991; 103(3):398-406. PubMed ID: 1711704
[TBL] [Abstract][Full Text] [Related]
2. Long-term effects of neonatal exposure to isobutylmethylxanthine. I. Retardation of learning with antagonism by mianserin.
Neal BS; Sparber SB
Psychopharmacology (Berl); 1991; 103(3):388-97. PubMed ID: 1711703
[TBL] [Abstract][Full Text] [Related]
3. The serotonin2 antagonist ritanserin blocks quasi-morphine withdrawal at a time when mianserin is no longer effective.
Neal BS; Sparber SB
Psychopharmacology (Berl); 1990; 100(2):258-66. PubMed ID: 1689501
[TBL] [Abstract][Full Text] [Related]
4. Morphine blocks and naloxone enhances suppression of operant behavior by low doses of 3-isobutyl-1-methylxanthine.
Kleven MS; Sparber SB
J Pharmacol Exp Ther; 1989 Jan; 248(1):273-7. PubMed ID: 2464058
[TBL] [Abstract][Full Text] [Related]
5. Modification of quasi-morphine withdrawal with serotonin agonists and antagonists: evidence for a role of serotonin in the expression of opiate withdrawal.
Kleven MS; Sparber SB
Psychopharmacology (Berl); 1989; 98(2):231-5. PubMed ID: 2474176
[TBL] [Abstract][Full Text] [Related]
6. Attenuation of isobutylmethylxanthine-induced suppression of operant behavior by pretreatment of rats with clonidine.
Kleven MS; Sparber SB
Pharmacol Biochem Behav; 1987 Oct; 28(2):235-41. PubMed ID: 2446338
[TBL] [Abstract][Full Text] [Related]
7. Mianserin attenuates naloxone-precipitated withdrawal signs in rats acutely or chronically dependent upon morphine.
Neal BS; Sparber SB
J Pharmacol Exp Ther; 1986 Jan; 236(1):157-65. PubMed ID: 3001281
[TBL] [Abstract][Full Text] [Related]
8. Clonidine suppresses methylxanthine induced quasi-morphine withdrawal syndrome.
Grant SJ; Redmond DE
Pharmacol Biochem Behav; 1982 Oct; 17(4):655-8. PubMed ID: 6184732
[TBL] [Abstract][Full Text] [Related]
9. Conditioning processes contribute to severity of naloxone-precipitated withdrawal from acute opioid dependence.
Schulteis G; Morse AC; Liu J
Psychopharmacology (Berl); 2004 Oct; 175(4):463-72. PubMed ID: 15083263
[TBL] [Abstract][Full Text] [Related]
10. Assessing physiological dependence and withdrawal potential of mitragynine using schedule-controlled behaviour in rats.
Harun N; Johari IS; Mansor SM; Shoaib M
Psychopharmacology (Berl); 2020 Mar; 237(3):855-867. PubMed ID: 31832720
[TBL] [Abstract][Full Text] [Related]
11. Repeated experience with naloxone facilitates acute morphine withdrawal: potential role for conditioning processes in acute opioid dependence.
Schulteis G; Morse AC; Liu J
Pharmacol Biochem Behav; 2003 Dec; 76(3-4):493-503. PubMed ID: 14643849
[TBL] [Abstract][Full Text] [Related]
12. Relative potency of the opioid antagonists naloxone and 6-alpha-naloxol to precipitate withdrawal from acute morphine dependence varies with time post-antagonist.
Schulteis G; Chiang D; Archer C
Pharmacol Biochem Behav; 2009 Mar; 92(1):157-63. PubMed ID: 19061911
[TBL] [Abstract][Full Text] [Related]
13. Conditioned place aversion is a highly sensitive index of acute opioid dependence and withdrawal.
Azar MR; Jones BC; Schulteis G
Psychopharmacology (Berl); 2003 Oct; 170(1):42-50. PubMed ID: 12783156
[TBL] [Abstract][Full Text] [Related]
14. In vivo and in vitro studies with agents that cause quasi-morphine withdrawal syndromes.
Sheldon RJ; Cowan A
Life Sci; 1982 Oct 18-25; 31(16-17):1699-702. PubMed ID: 6185813
[TBL] [Abstract][Full Text] [Related]
15. Acute opiate withdrawal in rats undernourished during infancy: impact of the undernutrition method.
Cohen CA; Tonkiss J; Sparber SB
Pharmacol Biochem Behav; 1991 Jun; 39(2):329-35. PubMed ID: 1946574
[TBL] [Abstract][Full Text] [Related]
16. The attenuation of delta 9-tetrahydrocannabinol and morphine of the quasi-morphine withdrawal syndrome in rats.
Zaluzny SG; Chesher GB; Jackson DM; Malor R
Psychopharmacology (Berl); 1979 Mar; 61(2):207-16. PubMed ID: 86997
[TBL] [Abstract][Full Text] [Related]
17. Antagonist-precipitated opioid withdrawal in rats: evidence for dissociations between physical and motivational signs.
Higgins GA; Sellers EM
Pharmacol Biochem Behav; 1994 May; 48(1):1-8. PubMed ID: 8029278
[TBL] [Abstract][Full Text] [Related]
18. Character and meaning of quasi-morphine withdrawal phenomena elicited by methylxanthines.
Collier HO; Cuthbert NJ; Francis DL
Fed Proc; 1981 Apr; 40(5):1513-8. PubMed ID: 6163662
[TBL] [Abstract][Full Text] [Related]
19. 3-Isobutyl-1-methylxanthine inhibits basal mu-opioid receptor phosphorylation and reverses acute morphine tolerance and dependence in mice.
Wang Z; Bilsky EJ; Wang D; Porreca F; Sadée W
Eur J Pharmacol; 1999 Apr; 371(1):1-9. PubMed ID: 10355588
[TBL] [Abstract][Full Text] [Related]
20. Brain reward deficits accompany naloxone-precipitated withdrawal from acute opioid dependence.
Liu J; Schulteis G
Pharmacol Biochem Behav; 2004 Sep; 79(1):101-8. PubMed ID: 15388289
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
